Record ID | marc_laurentian/openlibrary.mrc:755570165:938 |
Source | The Laurentian Library |
Download Link | /show-records/marc_laurentian/openlibrary.mrc:755570165:938?format=raw |
LEADER: 00938nama 2200229| 4500
001 200708272112
005 20070615160338.0
008 050323
020 $a1894620356
035 $a(Sirsi) a810581
060 $aWE 348 .M186c 2002
100 1 $aMaetzel, Andreas., Krahn, Murray., Naglie, Gary
245 10 $aThe cost-effectiveness of Celecoxib and Rofecoxib in patients with osteoarthritis or rheumatoid arthritis/$cCanadian Coordinating Office for Health Technology Assessment
260 $aOttawa:$bCanadian Coordinating Office for Health Technology Assessment,$c2002
300 $avii, 39 p.; ill; 28 cm.
500 $a"February 2002" Technology Report
650 $aArthritis, rheumatoid -- drug therapy
650 $aOsteoarthritis -- drug therapy
650 $a
852 $aIN$hWE 348 .M186c 2002$p306
596 $a2
999 $aWE348 .M186c 2002$wLC$c1$i810581-1001$lINPROCESS$mNEORCC$rY$sY$tBOOKS$u29/8/2007